Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.59 |
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.58 |
| ▸ | MPO | P05164 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20615042 | 0.92 | CHRM2 (0.52) | CHRM2TAAR1MPOMAPTHTT | |
| SCHEMBL9201570 | 0.90 | CHRM2 (0.50) | CHRM2TAAR1MPOMAPTHTT | |
| SCHEMBL10725177 | 0.89 | TAAR1 (0.52) | CHRM2TAAR1MPOMAPTHTT | |
| Hydrochloric Acid SCHEMBL9207321 | 0.88 | CHRM2 (0.49) | CHRM2TAAR1MPOMAPTHTT | |
| SCHEMBL16268723 | 0.87 | CHRM2 (0.47) | CHRM2TAAR1 | |
| SCHEMBL9490687 | 0.87 | CHRM2 (0.56) | CHRM2TAAR1MAPT | |
| SCHEMBL19405245 | 0.84 | ALDH1A1 (0.51) | CHRM2TAAR1MPOMAPTMEN1 | |
| SCHEMBL3057770 | 0.84 | TAAR1 (0.61) | CHRM2TAAR1MAPTHTTMEN1 | |
| SCHEMBL3207836 | 0.84 | ITGB3 (0.49) | CHRM2TAAR1MAPTHTTMEN1 | |
| SCHEMBL8096347 | 0.82 | SIGMAR1 (0.69) | CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190248958-A1 | PREPARATION METHOD OF OLIGOMER ADDITIVE, OLIGOMER ADDITIVE, AND LITHIUM BATTERY | NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (TW) | 2019-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190248958-A1 | PREPARATION METHOD OF OLIGOMER ADDITIVE, OLIGOMER ADDITIVE, AND LITHIUM BATTERY | PCNA, SCO2, PARG | CHRM2 963/4885TAAR1 2580/4885MPO 2929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.